The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Cineworld Reports "Good" Demand Despite Virus

Fri, 06th Mar 2020 07:43

(Alliance News) - Stock prices in London are set to open lower on Friday on growing investor worries, as governments revealed plans to help tackle the coronavirus crisis.

IG futures indicate the FTSE 100 index is to open 118.73 points, or 1.8%, lower at 6,586.70. The FTSE 100 index closed down 110.16 points, or 0.6%, at 6,705.43. The large-cap index ended lower after three straight days of gains.

The pound was quoted at USD1.2971 early Friday, firm from USD1.2922 at the London equities close Thursday. The euro was at USD1.1227 early Friday, firm from USD1.1185 late Thursday.

The European Central Bank meets next week to consider an action plan to deal with the mounting economic fallout from the coronavirus. But analysts question whether the bank have the monetary firepower to head off the risks resulting from the Covid-19 epidemic.

Christine Lagarde is facing her first major test as ECB president, as the central bank tries to navigate the economic storm unleashed by the spread of the coronavirus around the world.

At the start of the year, analysts had expected little immediate change in the ECB's approach under Lagarde's leadership after she launched a major review of the Frankfurt-based bank's policy instruments.

"Various governments around the world have revealed plans to help control the situation, but after a while dealers started to wonder how bad is the crisis if all these governments are so desperate to announce packages aimed to alleviating the problem. At a certain point, government intervention increases nervousness, and that is what we saw yesterday," said CMC Markets UK analyst David Madden.

"It was a painful day for stock markets yesterday as the number of confirmed cases of coronavirus increased, so the old fears returned to the surface," added Madden.

World health officials have warned that countries are not taking the coronavirus crisis seriously enough, as outbreaks surged across Europe and in the US where medical workers sounded warnings over a "disturbing" lack of hospital preparedness.

Global markets tumbled again Thursday over concerns about the impact on the economy and as countries took more drastic steps to prevent contagion of a disease that has killed more than 3,300 people and infected nearly 100,000 in about 85 nations.

Cases soared in Italy, France, Greece and Iran, while a cruise ship was held off the coast of California to test passengers showing symptoms of the disease – echoing a harrowing episode in Japan several weeks ago that saw hundreds infected on a luxury liner.

The Dow Jones Industrial Average dropped 969.58 points, or 3.6%. The S&P 500 lost 3.4% and the Nasdaq Composite 3.1%.

Against the yen, the dollar was trading at JPY105.89 early Friday in London, down from JPY106.73 late Thursday.

The Nikkei 225 index closed down 2.7% in Tokyo. The Hang Seng index in Hong Kong is down 2.2%. The Shanghai Composite closed down 1.2%.

In early company news, Cineworld Group said it has not "observed any material impact" on its movie theatre admissions due to coronavirus, despite the release of the new James Bond movie postponed to November.

Following an increase in admissions in the first two months of the year, against the same period in the previous year, Cineworld said it continues to see "good" levels of admissions in all of its territories.

Looking ahead, the cinema operator noted that there can be no certainty as to the future impact of COVID-19, but it is taking measures to ensure that it is prepared its business for all possible eventualities.

London-based insurer Aviva has agreed to exit Indonesia by selling its entire shareholding in its joint venture PT Astra Aviva Life to its partner PT Astra International.

This transaction is expected to complete in the final quarter of 2020 and is subject to certain closing conditions, including regulatory approval in Indonesia and the completion of Bangkok Bank Public Co Ltd's acquisition of PT Bank Permata. The shareholders of Bangkok Bank approved the acquisition of Permata Bank on Thursday, Aviva noted.

AstraZeneca said the phase III Danube trial for Imfinzi and Imfinzi plus tremelimumab did not meet the primary endpoints of improving overall survival versus standard-of-care chemotherapy in patients with stage IV bladder cancer.

"The results from this trial will inform our comprehensive phase III development programme in bladder cancer," said Executive Vice President Of Oncology R&D Jose Baselga.

Imfinzi is currently approved for patients with locally advanced or metastatic bladder cancer previously treated with platinum-containing chemotherapy in 15 countries, including the US.

"AstraZeneca remains committed to addressing unmet needs in bladder cancer and the potential for immunotherapy to improve outcomes for these patients," added Baselga.

Among those reporting results, Murray International Trust said it underperformed its benchmark in 2019, with net asset value total return at 12% compared to the 21% returned by its benchmark - a combination of 40% of FTSE World UK Index and 60% of FTSE World ex UK Index.

Murray reported NAV per share as at the end of 2019 of 1,190.0p compared to 1,107.8p reported on the same day a year earlier.

The investment company said it will be paying a dividend of 53.5 pence for 2019, up from 51.5p paid a year earlier.

Looking forward, Murray said it will continue to invest in opportunities across the globe that are not wholly tied to the developed economies and markets.

In addition, Murray appointed Simon Fraser as an independent non-executive director from the start of May.

Fraser had sat on a number of listed company boards in the past, including Barclays and Ashmore. He is currently chair of McInroy & Wood Ltd, the Investor Forum and the independent research boutique TS Lombard. He is also on the board of Fidelity Funds SICAV, Treasurer of the Kings Fund and a trustee of the Abbotsford Trust.

Alliance Trust reported a 21% surge in its NAV per share, which stood at 875.9p as at December 31 versus 723.6p a year ago. The investment company said its total return of 24% outperformed its benchmark, the MSCI All Country World Index (MSCI ACWI), which returned 22%.

Alliance Trust said it will be paying a 13.96p dividend for the year, up 3.0% from 13.55p paid the year before.

"During 2019, we completed the simplification of the trust by selling our subsidiary, Alliance Trust Savings, and virtually all our remaining non-core assets. As a result, we are now fully focused on global equities, something the Board has been working towards for the last four years," said Chair Gregor Stewart.

Looking ahead, the trust added that it expects its new streamlined structure to lead to continued improvement in returns to shareholders.

The economic events calendar on Friday has the US jobs report for February at 1330 GMT.

In commodities, gold was quoted at USD1,670.63 an ounce early Friday, higher than USD1,658.87 late Thursday. Brent oil was at USD49.63 a barrel, down from USD50.91.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.